Citalopram associated with acute angle-closure glaucoma: Case report

被引:28
|
作者
Croos R. [1 ]
Thirumalai S. [3 ]
Hassan S. [2 ]
Davis J.D.R. [1 ]
机构
[1] Department of Psychiatry, Prospect Park Hospital, Reading
[2] Department of Ophthalmology, Royal Berkshire Hospital, Reading
[3] Department of Psychiatry, Marlborough House Regional Secure Unit, Milton Keynes Hospital Site, Eaglestone, Milton Keynes, MK6 5NG, Standing Way
关键词
Glaucoma; Selective Serotonin Reuptake Inhibitor; Venlafaxine; Retinal Hemorrhage; Anterior Chamber Depth;
D O I
10.1186/1471-2415-5-23
中图分类号
学科分类号
摘要
Background: Acute angle-closure glaucoma is a rare complication in patients receiving antidepressant treatment. In the following case, we report the development of acute angle closure glaucoma in a patient who overdosed on Citalopram, an antidepressant, and discuss the possible etiological mechanisms for the condition. Case presentation: We report a 54 year old, Caucasian lady, with depression and alcohol dependence syndrome, who developed acute angle-closure glaucoma after an overdose of Citalopram, along with alcohol. She was treated with medications and had bilateral Yag laser iridotomies to correct the glaucoma and has made complete recovery. In this case, the underlying cause for glaucoma appears to be related to the ingestion of Citalopram. Conclusion: The patho-physiological basis for acute angle closure glaucoma in relation to antidepressant medications remains unclear. The authors suggest Citalopram may have a direct action on the Iris or Ciliary body muscle through serotonergic or anti-cholinergic mechanisms or both. This case highlights the importance of the awareness of the underlying risks, which may predispose an individual to develop acute angle-closure glaucoma, and reminds the clinicians the significance of history taking and examination of the eye before and after starting anti-depressants. This area needs to be further researched. © 2005 Croos et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条